CompoAtlas

Monalisan capsule 250mg

Monalisan capsule 250mg : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Registration number
MAL06061470T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
SHANGHAI CHATLIN PHARMACEUTICAL COMPANY
Manufacturer
SHANGHAI CHATLIN PHARMACEUTICAL COMPANY
Registration date
2026-07-03
Published validity end
2031-07-03

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Rhizoma Pinellia Ternata Thunb.Rhizoma Pinellia Ternata Thunb.[22.5;mg;250;mg]Not identified
Rhizoma Ligusticum chuanxiong.Rhizoma Ligusticum chuanxiong.[16;mg;250;mg]Not identified
Rhizoma Atractylodes chinensisRhizoma Atractylodes chinensis[16.5;mg;250;mg]Not identified
Rhizoma Alismatis OrientalisRhizoma Alismatis Orientalis[22.5;mg;250;mg]Not identified
Poria Cocos (Schw) WolfPoria Cocos (Schw) Wolf[25;mg;250;mg]Not identified
Pericarpium Citrus reticulata.Pericarpium Citrus reticulata.[20;mg;250;mg]Not identified
Herba Plantago asiaticaHerba Plantago asiatica[22.5;mg;250;mg]Not identified
Herba Artemisia AnnuaHerba Artemisia Annua[22.5;mg;250;mg]Not identified
Fructus Citrus aurantiumFructus Citrus aurantium[10;mg;250;mg]Not identified
Exocarpium Benincasa HispidaExocarpium Benincasa Hispida[22.5;mg;250;mg]Not identified
areca catecuareca catecu[20;mg;250;mg]Not identified
Rhizoma Atractylodes MacrocephalaRhizoma Atractylodes Macrocephala[22.5;mg;250;mg]Not identified
Rhizoma Cyperus Rotundus L.Rhizoma Cyperus Rotundus L.[7.5;mg;250;mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Active ingredients
Rhizoma Pinellia Ternata Thunb.[22.5;mg;250;mg],Rhizoma Ligusticum chuanxiong.[16;mg;250;mg],Rhizoma Atractylodes chinensis[16.5;mg;250;mg],Rhizoma Alismatis Orientalis[22.5;mg;250;mg],Poria Cocos (Schw) Wolf[25;mg;250;mg],Pericarpium Citrus reticulata.[20;mg;250;mg],Herba Plantago asiatica[22.5;mg;250;mg],Herba Artemisia Annua[22.5;mg;250;mg],Fructus Citrus aurantium[10;mg;250;mg],Exocarpium Benincasa Hispida[22.5;mg;250;mg],areca catecu[20;mg;250;mg],Rhizoma Atractylodes Macrocephala[22.5;mg;250;mg],Rhizoma Cyperus Rotundus L.[7.5;mg;250;mg]
Valid until
2031-07-03
Registration date
2026-07-03
Published description
NATURAL PRODUCT
Licence holder
SHANGHAI CHATLIN PHARMACEUTICAL COMPANY
Producer
SHANGHAI CHATLIN PHARMACEUTICAL COMPANY
Published name
Monalisan capsule 250mg
Published reference
2005061739108
Registration number
MAL06061470T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL06061470T

Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line